| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.11. | Tivic Health Systems: Tivic Secures Barda Meeting for Entolimod for Acute Radiation Syndrome | 316 | ACCESS Newswire | Meeting with Radiological and Nuclear Medical Countermeasures Program FREMONT, CA / ACCESS Newswire / November 18, 2025 / Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage therapeutics company... ► Artikel lesen | |
| 14.11. | Earnings Call: Strategiewechsel bei Tivic Health Systems belastet Ergebnis und Aktie | 1 | Investing.com Deutsch | ||
| 14.11. | Tivic Health Systems GAAP EPS of -$1.97, revenue of $0.15M | 4 | Seeking Alpha | ||
| 14.11. | Tivic Health Systems: Tivic Reports Third Quarter 2025 Financial Results | 1.991 | ACCESS Newswire | Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified immunotherapeutics... ► Artikel lesen | |
| TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 13.11. | Tivic Health erzielt Fortschritte bei der Optimierung der Nervenstimulation | 1 | Investing.com Deutsch | ||
| 13.11. | Tivic Health optimizes nerve stimulation parameters in new study | 3 | Investing.com | ||
| 13.11. | Tivic Health Systems: Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation | 238 | ACCESS Newswire | The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire / November 13, 2025 / Tivic Health Systems, Inc.... ► Artikel lesen | |
| 13.11. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.11. | Tivic Health files two new patents for cancer and bioelectronic therapies | 1 | Investing.com | ||
| 10.11. | Tivic Health erweitert Patentportfolio für Krebs- und bioelektronische Therapien | 1 | Investing.com Deutsch | ||
| 17.10. | Tivic Health files to sell 1.58M shares of common stock for holders | 1 | Seeking Alpha | ||
| 15.10. | Tivic Health Systems und CEO Jennifer Ernst vereinbaren neuen Anstellungsvertrag | 1 | Investing.com Deutsch | ||
| 15.10. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.08. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Tivic Health receives two INDs for Entolimod from Statera Biopharma | 11 | Investing.com | ||
| 20.08. | Tivic Health sichert sich zwei IND-Anträge für Medikamentenkandidaten Entolimod | 12 | Investing.com Deutsch | ||
| 20.08. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.08. | Tivic Health stock soars as company advances military radiation countermeasure | 3 | Investing.com | ||
| 15.08. | Tivic Health: Aktie schießt nach Fortschritten bei militärischem Strahlenschutz in die Höhe | 2 | Investing.com Deutsch | ||
| 15.08. | Tivic Health signals exit from consumer health tech while advancing $19B+ immunotherapy market pipeline | 3 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 158,96 | 0,00 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 29,380 | -2,07 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,470 | +1,83 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | 0,00 % | Nutex Health extends share repurchase plan | ||
| FRESENIUS MEDICAL CARE | 40,050 | +0,10 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,310 | 0,00 % | Aveanna Healthcare stock price target raised to $13 by Raymond James | ||
| CERIBELL | 19,720 | +2,98 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| GOODRX | 2,710 | 0,00 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? | ||
| CLEARPOINT NEURO | 13,540 | -3,70 % | Here's What Boosted ClearPoint Neuro (CLPT) in Q3 | ||
| ADAPTHEALTH | 9,420 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| RXSIGHT | 12,660 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen |